Search Results - "GOLDE, Todd E"

Refine Results
  1. 1

    Alzheimer's disease - the journey of a healthy brain into organ failure by Golde, Todd E

    Published in Molecular neurodegeneration (05-03-2022)
    “…As the most common dementia, Alzheimer's disease (AD) exacts an immense personal, societal, and economic toll. AD was first described at the neuropathological…”
    Get full text
    Journal Article
  2. 2

    MAPT mutations, tauopathy, and mechanisms of neurodegeneration by Strang, Kevin H., Golde, Todd E., Giasson, Benoit I.

    Published in Laboratory investigation (01-07-2019)
    “…In multiple neurodegenerative diseases, including Alzheimer's disease (AD), a prominent pathological feature is the aberrant aggregation and inclusion…”
    Get full text
    Journal Article
  3. 3

    Alzheimer's disease: The right drug, the right time by Golde, Todd E, DeKosky, Steven T, Galasko, Douglas

    “…Lessons from failed clinical trials can improve the development of Alzheimer's disease–modifying therapies Alzheimer's disease (AD) is an age-associated…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain by Chakrabarty, Paramita, Rosario, Awilda, Cruz, Pedro, Siemienski, Zoe, Ceballos-Diaz, Carolina, Crosby, Keith, Jansen, Karen, Borchelt, David R, Kim, Ji-Yoen, Jankowsky, Joanna L, Golde, Todd E, Levites, Yona

    Published in PloS one (25-06-2013)
    “…Adeno-associated virus (AAV) mediated gene expression is a powerful tool for gene therapy and preclinical studies. A comprehensive analysis of CNS cell type…”
    Get full text
    Journal Article
  6. 6

    γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct by Ran, Yong, Hossain, Fokhrul, Pannuti, Antonio, Lessard, Christian B, Ladd, Gabriela Z, Jung, Joo In, Minter, Lisa M, Osborne, Barbara A, Miele, Lucio, Golde, Todd E

    Published in EMBO molecular medicine (01-07-2017)
    “…γ‐Secretase inhibitors (GSIs) are being actively repurposed as cancer therapeutics based on the premise that inhibition of NOTCH1 signaling in select cancers…”
    Get full text
    Journal Article
  7. 7

    Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study by Ofori, Edward, Pasternak, Ofer, Planetta, Peggy J, Burciu, Roxana, Snyder, Amy, Febo, Marcelo, Golde, Todd E, Okun, Michael S, Vaillancourt, David E

    Published in Neurobiology of aging (01-02-2015)
    “…Abstract Measures from diffusion magnetic resonance imaging reflect changes in the substantia nigra of Parkinson's disease. It is the case, however, that…”
    Get full text
    Journal Article
  8. 8

    Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction by Kim, Ji-Yoen, Grunke, Stacy D, Levites, Yona, Golde, Todd E, Jankowsky, Joanna L

    Published in Journal of visualized experiments (15-09-2014)
    “…With the pace of scientific advancement accelerating rapidly, new methods are needed for experimental neuroscience to quickly and easily manipulate gene…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Thinking laterally about neurodegenerative proteinopathies by Golde, Todd E, Borchelt, David R, Giasson, Benoit I, Lewis, Jada

    Published in The Journal of clinical investigation (01-05-2013)
    “…Many neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and frontotemporal dementia, are proteinopathies…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph by Magno, Lorenza, Lessard, Christian B., Martins, Marta, Lang, Verena, Cruz, Pedro, Asi, Yasmine, Katan, Matilda, Bilsland, Jamie, Lashley, Tammaryn, Chakrabarty, Paramita, Golde, Todd E., Whiting, Paul J.

    Published in Alzheimer's research & therapy (02-02-2019)
    “…© The Author(s). 2019 Open Access © This article is distributed under the terms of the Creative Commons Attribution 4.0 International License…”
    Get full text
    Journal Article
  13. 13

    High‐affinity interactions and signal transduction between Aβ oligomers and TREM2 by Lessard, Christian B, Malnik, Samuel L, Zhou, Yingyue, Ladd, Thomas B, Cruz, Pedro E, Ran, Yong, Mahan, Thomas E, Chakrabaty, Paramita, Holtzman, David M, Ulrich, Jason D, Colonna, Marco, Golde, Todd E

    Published in EMBO molecular medicine (01-11-2018)
    “…Rare coding variants in the triggering receptor expressed on myeloid cells 2 (TREM2) are associated with increased risk for Alzheimer's disease (AD), but how…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease by Born, Heather A, Kim, Ji-Yoen, Savjani, Ricky R, Das, Pritam, Dabaghian, Yuri A, Guo, Qinxi, Yoo, Jong W, Schuler, Dorothy R, Cirrito, John R, Zheng, Hui, Golde, Todd E, Noebels, Jeffrey L, Jankowsky, Joanna L

    Published in The Journal of neuroscience (12-03-2014)
    “…Alzheimer's disease (AD) is associated with an elevated risk for seizures that may be fundamentally connected to cognitive dysfunction. Supporting this link,…”
    Get full text
    Journal Article
  16. 16

    Precision therapeutic targets for COVID-19 by Krumm, Zachary A, Lloyd, Grace M, Francis, Connor P, Nasif, Lith H, Mitchell, Duane A, Golde, Todd E, Giasson, Benoit I, Xia, Yuxing

    Published in Virology journal (29-03-2021)
    “…Beginning in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a novel pathogen that causes coronavirus disease 2019…”
    Get full text
    Journal Article
  17. 17
  18. 18

    A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies by Dhillon, Jess-Karan S, Riffe, Cara, Moore, Brenda D, Ran, Yong, Chakrabarty, Paramita, Golde, Todd E, Giasson, Benoit I

    Published in PloS one (14-09-2017)
    “…Synucleinopathies are a spectrum of neurodegenerative diseases characterized by the intracellular deposition of the protein α-synuclein leading to multiple…”
    Get full text
    Journal Article
  19. 19

    Increased brain hemopexin levels improve outcomes after intracerebral hemorrhage by Leclerc, Jenna L, Santiago-Moreno, Juan, Dang, Alex, Lampert, Andrew S, Cruz, Pedro E, Rosario, Awilda M, Golde, Todd E, Doré, Sylvain

    “…Following intracerebral hemorrhage (ICH), extracellular heme precipitates secondary brain injury, which results in irreversible brain damage and enduring…”
    Get full text
    Journal Article
  20. 20

    Notch signaling is activated by TLR stimulation and regulates macrophage functions by Palaga, Tanapat, Buranaruk, Chayanit, Rengpipat, Sirirat, Fauq, Abdul H, Golde, Todd E, Kaufmann, Stefan H.E, Osborne, Barbara A

    Published in European journal of immunology (01-01-2008)
    “…Notch signaling is a well-conserved pathway involved in cell fate decisions, proliferation and apoptosis. We report on the involvement of Notch signaling in…”
    Get full text
    Journal Article